UNITED
STATES
SECURITIES
AND EXCHANGE COMMISSION
WASHINGTON,
DC 20549
FORM
8-K
CURRENT
REPORT
Pursuant
to Section 13 or 15(d) of the
Securities
Exchange Act of 1934
Date of
report (Date of earliest event reported): September 8,
2008
(Exact
name of registrant as specified in its charter)
|
New
Jersey
|
I-3215
|
22-1024240
|
|
(State
or Other Jurisdiction of Incorporation)
|
(Commission
File Number)
|
(IRS
Employer Identification No.)
|
One
Johnson & Johnson Plaza, New Brunswick, New
Jersey 08933
(Address
of Principal Executive Offices) (Zip Code)
Registrant’s
telephone number, including area code: 732-524-0400
Check the
appropriate box below if the Form 8-K filing is intended to simultaneously
satisfy the filing obligation of the registrant under any of the following
provisions:
o Written
communications pursuant to Rule 425 under the Securities Act (17 CFR
230.425)
o Soliciting
material pursuant to Rule 14a-12 under the Exchange Act (17 CFR
240.14a-12)
o Pre-commencement
communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR
240.14d-2(b))
o Pre-commencement
communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR
240.13e-4(c))
Item
5.02. Departure of Directors or Certain Officers; Election of
Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain
Officers.
On
September 12, 2008, the Company announced that Christine A. Poon, 56, Vice
Chairman of the Board of Directors and Worldwide Chairman, Pharmaceuticals
Group, has announced plans to retire on March 1, 2009 from the Company and the
Board. Ms. Poon began her career with the Company in 2000 and
was elected to the Company’s Board of Directors and named a Vice Chairman of the
Board in 2005. The related press release dated September 12, 2008 is
attached as Exhibit 99.1 to this Report.
SIGNATURES
Pursuant
to the requirements of the Securities Exchange Act of 1934, the Registrant has
duly caused this Report to be signed on its behalf by the undersigned hereunto
duly authorized.
|
Johnson
& Johnson
|
|||
|
(Registrant)
|
|||
|
Date: September
12, 2008
|
By:
|
/s/ STEVEN
M. ROSENBERG
|
|
|
Steven
M. Rosenberg
|
|||
|
Secretary
|
|||
EXHIBIT
INDEX
Exhibit
No.
Description
99.1
Press release dated September 12, 2008